Janus Henderson Group PLC Schedule 13G passive stakes

Janus Henderson Group plc has reported a 5.2% beneficial ownership stake in Olema Pharmaceuticals, Inc., holding 3,585,849 shares of common stock.

Janus Henderson Group plc has reported a 5.3% beneficial ownership stake in API Group Corp's common stock, totaling 22,228,439 shares.

Janus Henderson Group plc has reported a 6.4% beneficial ownership stake in Biohaven Ltd. common stock.

Janus Henderson Group PLC has filed an amended Schedule 13G, reporting a beneficial ownership of 1.2% in Verona Pharma PLC's American Depositary Shares.

Janus Henderson Group plc has filed an Amendment No. 11 to its Schedule 13G, reporting a 2.3% beneficial ownership stake in Amdocs Limited as of September 30, 2025.

Janus Henderson Group plc has reported an increased beneficial ownership of 4.7% in Edgewise Therapeutics, Inc., holding 4,979,331 common shares.

Janus Henderson Group plc has filed an amendment to its Schedule 13G, reporting beneficial ownership of 4.9% of Inspired Entertainment, Inc.'s common stock.

Janus Henderson Group plc has disclosed a 10.0% beneficial ownership stake in Janux Therapeutics, Inc., holding 6,033,949 shares of common stock.

Janus Henderson Group plc and its affiliates have disclosed a significant passive beneficial ownership stake of 12.1% in Enanta Pharmaceuticals Inc.

Janus Henderson Group plc has filed an amendment to its Schedule 13G, disclosing a reduction in its beneficial ownership in 89bio, Inc. common stock to 3.6%.

Janus Henderson Group plc has reported an 11.6% beneficial ownership stake in INVIVYD, INC., holding over 24 million shares of common stock.

Janus Henderson Group plc and its affiliate have reported a significant passive stake of 13.6% in Vistagen Therapeutics, Inc. common stock.

Janus Henderson Group plc and its affiliates reported a significant beneficial ownership stake of 11.3% in Benitec Biopharma Inc. common stock.

Janus Henderson Group plc has disclosed a 6.0% beneficial ownership stake in Maze Therapeutics, Inc., holding 2,625,089 common shares.

Janus Henderson Group plc and its affiliate reported increased beneficial ownership in Lexeo Therapeutics, Inc., holding 11.1% and 6.2% of common stock respectively.

Janus Henderson Group plc and its affiliate have increased their beneficial ownership in Forte Biosciences, Inc. to 9.9% of common stock.

Janus Henderson Group plc and its affiliates reported beneficial ownership of 11.3% of Benitec Biopharma Inc.'s common stock as of June 30, 2025.

Janus Henderson Group plc has disclosed a 5.0% beneficial ownership stake in Inspired Entertainment, Inc. common stock.

Janus Henderson Group plc has filed an amended Schedule 13G, reporting a 5.2% beneficial ownership stake in Amdocs Limited's Ordinary Shares.

Janus Henderson Group plc has filed an amended Schedule 13G, disclosing a 5.2% beneficial ownership stake in Edgewise Therapeutics, Inc. common stock.

Janus Henderson Group plc has disclosed a 5.4% beneficial ownership stake in TYRA Biosciences, Inc., holding 2,856,290 common shares.

Janus Henderson Group PLC has increased its beneficial ownership in Sensient Technologies Corporation to 5.5% of common stock, holding 2,332,704 shares.

Janus Henderson Group plc has disclosed an increased beneficial ownership of 5.5% in Ligand Pharmaceuticals Incorporated, holding 1,060,734 common shares.

Janus Henderson Group plc has filed an amended Schedule 13G, disclosing a 5.7% beneficial ownership stake in Rentokil Initial PLC as of June 30, 2025.

Janus Henderson Group plc has reported a 5.7% beneficial ownership stake in Revolution Medicines, Inc., holding over 10.5 million common shares.

Janus Henderson Group plc has filed an amended Schedule 13G, reporting a 6.3% beneficial ownership stake in OSI Systems, Inc. as of June 30, 2025.

Janus Henderson Group plc has increased its beneficial ownership in Ardelyx, Inc. to 6.3% of common stock, holding over 15 million shares.

Janus Henderson Group plc and its affiliates disclosed an increased beneficial ownership of ASURE SOFTWARE INC's Class A Common Stock, reaching 6.3% as of June 30, 2025.

Janus Henderson Group plc has disclosed an increased beneficial ownership of 6.6% in Gildan Activewear Inc. common stock.

Janus Henderson Group plc has increased its beneficial ownership in SS&C Technologies Holdings, Inc. to 6.7% of common stock, holding 16,495,178 shares.